REMEDY Raises Series A Led by L Catterton to Modernize Dermatologist-Developed Skincare

Source Summary

LOS ANGELES--(BUSINESS WIRE)--Remedy Science (“REMEDY”), the dermatologist-developed, education-first skincare brand translating clinical expertise into accessible, high-performance products, today announced the closing of its Series A funding round led by L Catterton, the largest global consumer-focused investment firm, with participation from existing investor Norwest and new investor Sonoma Brands Capital. Founded by board-certified dermatologist Dr. Muneeb Shah, REMEDY was created to mirror